Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore” or the “Group”), the company delivering a new generation of nanopore-based molecular sensing technology, today announces the expansion of the leadership team to support the business in its next phase of growth. Following a comprehensive search process, Nick Keher has been appointed as Chief Financial Officer (“CFO”) […]
Helge Bastian, PhD, joins executive team as new CEO. SAN DIEGO — iXCells Biotechnologies USA, Inc. (“iXCells”), a cell technology company specializing in providing cell-based products and drug discovery service solutions to the global academic, biotech, pharmaceutical, and rare disease communities, today announced the appointment of Helge Bastian, PhD, as the company’s new Chief Executive […]
* Senior biopharma and cell therapy engineering/operations executive with 30+ years of experience to help drive growth FORT LAUDERDALE, Fla. and WEST SACRAMENTO, Calif. — Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Steven Sandoval, Sr., to its Board of […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the Board of Directors has elected Dalip M. Puri as Executive Vice President and Chief Financial Officer, effective April 2, 2024. Mr. Puri currently serves as Senior Vice President, Operational Finance. He will replace William J. Burke who has announced his retirement after 36 years with […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced that William J. Burke, AMETEK Executive Vice President and Chief Financial Officer, has decided to retire after 36 years of exceptional service, including nearly eight years as Chief Financial Officer. Mr. Burke’s retirement will be effective April 2, 2024. AMETEK’s Board of Directors has named Dalip M. […]
PARIS, France – Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its […]
CARLSBAD, Calif. — ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, announces Mark McDonough as Chair of the Board, the retirement of former Chair Carol Gallagher, Pharm.D., and the appointment of Michele Park, Ph.D. to the Board. Mark McDonough, CEO of ChromaCode, becomes Chair of the Board, effective January 1, 2024. Retiring Chair, Carol Gallagher commented, […]
Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced the establishment of its Scientific Advisory Board (SAB) to provide strategic guidance and consult on the Company’s efforts to […]
LAKEWOOD, Colo. — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us”, or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the “Board”), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim Kelderman, who will become Bio-Techne’s Chief Executive Officer effective February 1, 2024. Dr. McManus has over two decades of experience as a senior life sciences leader, most recently serving as […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
